| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.15B | +24.1% |
| Cost of Revenue | $4.56B | +21.0% |
| Gross Profit | $1.59B | +33.9% |
| R&D Expense | $374.0M | +6.6% |
| SG&A Expense | $344.0M | +12.1% |
| Operating Income | $292.0M | +1725.0% |
| Pre-tax Income | $346.0M | +1472.7% |
| Income Tax | $4.0M | +33.3% |
| Net Income | $342.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.35B | +49.8% |
| Accounts Receivable | $127.0M | +10.4% |
| Inventory | $114.0M | -3.4% |
| Current Assets | $2.67B | +35.1% |
| Total Assets | $3.15B | +30.6% |
| Current Liabilities | $969.0M | +19.5% |
| Total Liabilities | $1.02B | +18.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $661.0M | +83.6% |
| Investing Cash Flow | -$172.0M | -341.0% |
| Financing Cash Flow | $7.0M | -61.1% |
| +1700.0% |
| EPS (Basic) | $0.59 | +1866.7% |
| EPS (Diluted) | $0.56 | +1766.7% |
| Stockholders' Equity |
| $2.12B |
| +37.5% |